Gin Hwa Biotech Inc. (7806) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Gin Hwa Biotech Inc. (7806:TWSE), powered by AI.

Current Price
$65.00
Sector
Healthcare
What is the Gin Hwa Biotech Inc. stock price forecast?

Gin Hwa Biotech Inc. is currently trading at $65.00. View real-time AI analysis on Alpha Lenz.

What is Gin Hwa Biotech Inc. insider trading activity?

View the latest insider trading data for Gin Hwa Biotech Inc. on Alpha Lenz.

What is Gin Hwa Biotech Inc.'s P/E ratio?

View Gin Hwa Biotech Inc.'s valuation metrics on Alpha Lenz.

Gin Hwa Biotech Inc.

TWSE · 7806
NT$65.00+0.00(+0.00%)
Ask about Gin Hwa Biotech Inc.'s future dividend policy...
Alpha Chat Insight

Gin Hwa Biotech Inc.'s ROE is 12.1%. Explore profitability and growth together.

Ask for details

Company Overview

Gin Hwa Biotech Inc. is a Taiwan-based company specializing in the production, sales, and contract manufacturing of health and nutritional supplements. Leveraging over 30 years of manufacturing experience, the company offers a comprehensive range of product formats—including liquid, powdered, softgel, and capsule formulations—tailored for various consumer needs. Through its original equipment manufacturer (OEM) and original design manufacturer (ODM) services, Gin Hwa Biotech collaborates with leading health product brands, providing customized formula development, new dosage form consultations, and bespoke product design. Its advanced technology portfolio features concentrated extraction, fermentation, and ultrasonic processes, all designed to ensure product effectiveness, safety, and consistency. Gin Hwa Biotech also supplies medicinal materials and food ingredients, and is active in the development of beauty and body-shaping products. Certified under ISO22000, HACCP, GMP, and FSSC 22000 standards, the company maintains strict quality controls throughout its operations. Headquartered in Kaohsiung City, Gin Hwa Biotech plays a significant role in the personal care and household health sectors, supporting both local brands and international market participants through innovation-driven contract manufacturing and ingredient solutions.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$538.65MRevenue
0.00Shares Out
0Employees

Margins

30.40%Gross
25.27%EBITDA
17.07%Operating
17.67%Pre-Tax
13.99%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

56.90%Rev 3Yr
N/ARev 5Yr
40.63%Op Inc 3Yr
N/AOp Inc 5Yr
36.51%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

8.07%ROA
12.09%ROE
10.44%ROIC

Financial Health

NT$117.65MCash & Cash Equivalents
NT$215.15MNet Debt
42.99%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Gin Hwa Biotech Inc. (ticker: 7806) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 65 with a P/E ratio of -x and P/B of -x.

ROE is 12.09% and operating margin is 17.07%. Annual revenue is $539M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Gin Hwa Biotech Inc. (7806) Stock Forecast 2026 $65.00 — Price, Financials & Analyst Targets | Alpha Lenz